Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine Concentration for Brachial Plexus Block in Shoulder Surgery
NCT06640621Completed
- Sponsor
- Peking University Third Hospital
- Start
- Nov 2022
- Primary completion
- Oct 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Peking University Third Hospital. Primary endpoints: Maximum range of motion of bilateral diaphragm and Change rate of diaphragm thickness. Started Nov 2022; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06640621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06640621.